Ian Friedland is a Strategic Medical Advisor at Facile Therapeutics. Ian was previously the VP of Clinical Development at Cubist Pharmaceuticals from December 2009 to July 2014. Prior to that, they were the Chief Medical Officer at Calixa Pharmaceuticals from January 2009 to December 2009. Ian started their pharmaceutical career at J&J Pharmaceutical Research and Development in July 2005 as a Compound Development Lead and worked there until December 2008.
Ian Friedland is a medical doctor who specializes in pediatric infectious diseases. Ian received their MBBCh (MD) from the University of the Witwatersrand and did their fellowship in pediatric infectious diseases at UT Southwestern in Dallas.
Links